References
- Rognoni A, Cavallino C, Veia A, et al. Pathophysiology of atherosclerotic plaque development. Cardiovasc Hematol Agents Med Chem. 2015;13:10–13.
- Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011;473:317–325.
- Chen X, Li S, Yang Y, et al. Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease. J Thromb Haemost. 2012;10:1508–1514.
- van der Harst P, Verweij N. Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease. Circ Res. 2018;122:433–443.
- NINDS Stroke Genetics Network (SiGN) Genetics Network (SiGN). Loci associated with ischaemic stroke and its subtypes (SiGN): a genome-wide association study. Lancet Neurol. 2016;15:174–184.
- Violi F, Loffredo L, Carnevale R, et al. Atherothrombosis and oxidative stress: mechanisms and management in elderly. Antioxid Redox Signal. 2017;27:1083–1124.
- Pignatelli P, Menichelli D, Pastori D, et al. Oxidative stress and cardiovascular disease: new insights. Kardiol Pol. 2018;76:713–722.
- Singh S. Cytoprotective and regulatory functions of glutathione S-transferases in cancercell proliferation and cell death. Cancer Chemother Pharmacol. 2015;75:1–15.
- Zhang PY, Xu X, Li XC. Cardiovascular diseases: oxidative damage and antioxidant protection. Eur Rev Med Pharmacol Sci. 2014;18:3091–3096.
- Dusinská M, Ficek A, Horská A, et al. Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat Res. 2001;482:47–55.
- Santovito A, Cervella P, Delpero M. Baseline frequency of chromosomal aberrations and sister chromatid exchanges in peripheral blood lymphocytes of healthy individuals living in Turin (North-Western Italy): assessment of the effects of age, sex and GSTs gene polymorphisms on the levels of genomic damage. Ann Hum Biol. 2016;43:269–278.
- Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264–269, W64.
- Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605.
- Oliveira-Paula GH, Lacchini R, Tanus-Santos JE. Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases. Nitric Oxide. 2017;63:39–51.
- Ma WQ, Han XQ, Wang X, et al. Associations between XRCC1 gene polymorphisms and coronary artery disease: a meta-analysis. Plos One. 2016;11:e0166961.
- Xie X, Shi X, Liu M. The roles of TLR gene polymorphisms in atherosclerosis: a systematic review and meta-analysis of 35,317 subjects. Scand J Immunol. 2017;86:50–58.
- Liu A, Wan A, Feng A, et al. ICAM-1 gene rs5498 polymorphism decreases the risk of coronary artery disease. Medicine. 2018;97:e12523.
- Luo Z, Lu Z, Muhammad I, et al. Associations of the MTHFR rs1801133 polymorphism with coronary artery disease and lipid levels: a systematic review and updated meta-analysis. Lipids Health Dis. 2018;17:191.